Used in targeted cancer therapy, particularly in small cell lung cancer and pancreatic cancer. Binds to the NOTCH3 receptor to inhibit signaling pathways involved in tumor growth and cancer stem cell maintenance. Investigated in clinical trials to block tumor progression and improve patient outcomes, often in combination with chemotherapy. Shows potential for precision medicine approaches in NOTCH3-expressing tumors.